Bristol Myers Squibb Co said on Friday that U.S. regulators approved the first drug in a new class of cancer immunotherapies as an initial treatment for advanced melanoma, the deadliest form of skin cancer.
Quess Corp chairman Ajit Isaac and his wife Sarah Isaac have committed Rs 105 crore to set up the Isaac Centre for Public Health at the Indian Institute of Science (IISc) campus in Bengaluru by 2024. The objective is to create best-in-class post-grad
The increasing need for pharmaceuticals has led to the growing willingness to outsource drug development to Contract Drug Manufacturing Organizations (CDMOs).
Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India's first mRNA COVID vaccine to the regulator Drugs Controller General of India (DCGI) on Friday, said sources.
The Medicines Patent Pool (MPP) has granted licences to 19 Indian pharmaceutical firms to manufacture and commercialise the generic version of Paxlovid, Pfizer's oral antiviral Covid-19 pill.
Bharat Serums and Vaccines on Thursday said it has acquired a 26 per cent stake in AMP Energy C&I One to support green energy requirements for its manufacturing facility at Ambernath in Maharashtra. Aimed at driving a comprehensive sustainability blu
Corbevax, the Covid-19 vaccine used for children aged 12 to 14 years, is being sold to the government at only ₹145 per dose, Biological E said on Wednesday even as the country kick-started the vaccination
Mainly, pharmaceutical companies are faced with a constant stream of new data flowing into often siloed information systems.
Hidoc Dr, India's most comprehensive platform for doctors' networking, has launched a one-stop solution known as Key Opinion Leaders (KOL) Factory to bridge the gap between pharmaceutical businesses and India's top doctors in the wake of the Covid-19
The Covid-19 working group of the National Technical Advisory Group on Immunisation (NTAGI) will review data from a study conducted by Christian Medical College (CMC), Vellore on mixing and matching of Covid-19 vaccines-in a meeting to be held
, CDSCO.jpg)
